Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Thromboembolism Prophylaxis After Total Hip Arthroplasty or Total Knee Arthroplasty by a Risk Stratification With Thromboelastography for Asian Populations: A Randomized Control Trial

NCT03804697 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.

NCT NCT03804697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03804697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Thromboembolism Prophylaxis After Total Hip Arthroplasty or Total Knee Arthroplasty by a Risk Stratification With Thromboelastography for Asian Populations: A Randomized Control Trial
Lead sponsor
Guangdong Provincial People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2016
Completion date
January 1, 2018
Enrollment
197 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty complications, venous thrombosis, deep